Arrowhead Pharmaceuticals’ REDEMPLO (plozasiran), a small interfering RNA therapy, was recently approved by Australia’s Therapeutic Goods Administration as the first and only medicine to reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results